ERIK ISTRE: Open Payments
NPI 1912228669 · QUEENSBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,718 in 99 payments from 11 companies in 2025. Trend: 2023 $2,516 · 2024 $9,221 · 2025 $7,718
Speaker / faculty: $5,513Food & beverage: $2,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $6,858 |
| EMD Serono, Inc. | 2 | $210 |
| Novartis Pharmaceuticals Corporation | 23 | $184 |
| Genentech USA, Inc. | 2 | $137 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| SCILEX PHARMACEUTICALS INC. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Impel Pharmaceuticals LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: UBRELVY, QULIPTA, Mavenclad, KESIMPTA, ZEPOSIA, Ocrevus Zunovo, Sunosi, ZTLido.
Industry payments across NY — which companies pay providers there.
